BUCKEL DAVID A. enters SCOPUS BIOPHARMA INC. with 5.94K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Indirect Derivatives
Filed: 12/28/2020ACC: 0001104659-20-139928
5.94K
Baseline shares
0.00
Direct ownership
0 positions
100K
Derivative underlying
1 instrument
1
Security positions
5.94K indirect
Non-Derivative Holdings1
Common Stock, par value $0.001
IndirectShares owned5.94K
Total
5.94K indirect5.94K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.001 | 5.94K | Indirect |
| Total | 5.94K | 5.94K indirect |
Derivative Holdings1
Stock Options
DirectUnderlying security
Common Stock
Underlying shares
100K
Shares owned
N/A
Exercise price
5.50
Expiration
—
Exercise window
—
Total
Underlying
100K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Options Direct | Common Stock | 5.50 | — | — | 100K | N/A |
| Total | 100K | 0.00 | ||||